Androgen Deficiency and Phosphodiesterase Type 5 Expression Changes in Aging Male: Therapeutic Implications

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2019 May 22

PMID 31110491

Citations 11

Authors

Antonio Aversa

Ylenia Duca

Rosita Angela Condorelli

Aldo Eugenio Calogero

Sandro La Vignera

Affiliations

Soon will be listed here.

Abstract

The age-related decline of serum T occurs in ~20-30% of adult men and it is today defined as late-onset hypogonadism (LOH). In the elderly, such decline becomes more prevalent (up to 60%) and shows-up with erectile dysfunction (ED) and hypoactive sexual desire. A large body of experimental evidences have shown that the combination of T replacement therapy (TRT) and phosphodiesterase type 5 inhibitors (PDE5i) is, usually, effective in restoring erectile function in patients with LOH and ED who have not responded to monotherapy for sexual disturbances. In fact, PDE5is potentiate the action of nitric oxide (NO) produced by endothelial cells, resulting in a vasodilator effect, while T facilitates PDE5i effects by increasing the expression of PDE5 in corpora cavernosa. Meta-analytic data have recognized to PDE5i a protective role on the cardiovascular health in patients with decreased left ventricular ejection fraction. In addition, several studies have shown pleiotropic beneficial effects of these drugs throughout the body (i.e., on bones, urogenital tract and cerebral, metabolic, and cardiovascular levels). TRT itself is able to decrease endothelial dysfunction, oxidative stress and inflammation, thus lowering the cardiovascular risk. Furthermore, untreated hypogonadism could be the cause of PDE5i ineffectiveness especially in the elderly. For these reasons, aging men complaining ED who have LOH should undergo TRT before or at the moment when PDE5i treatment is started.

Citing Articles

Comprehensive RNA-seq analysis of benign prostatic hyperplasia (BPH) in rats exposed to testosterone and estradiol.

Tang X, Liu Z, Ren J, Zhang H, Tian Y, Hu J Sci Rep. 2025; 15(1):2750.

PMID: 39838074 PMC: 11751460. DOI: 10.1038/s41598-025-87205-2.

Runs of Homozygosity Islands in Autochthonous Spanish Cattle Breeds.

Hervas-Rivero C, Mejuto-Vazquez N, Lopez-Carbonell D, Altarriba J, Diaz C, Molina A Genes (Basel). 2024; 15(11).

PMID: 39596677 PMC: 11593383. DOI: 10.3390/genes15111477.

Phosphodiesterase 9A inhibition improves aging-related increase in pulmonary vascular resistance in mice.

Buncha V, Fopiano K, Lang L, Ilatovskaya D, Verin A, Bagi Z Geroscience. 2024; 46(5):5191-5202.

PMID: 38980632 PMC: 11335997. DOI: 10.1007/s11357-024-01270-5.

Management of Male Infertility with Coexisting Sexual Dysfunction: A Consensus Statement and Clinical Recommendations from the Asia-Pacific Society of Sexual Medicine (APSSM) and the Asian Society of Men's Health and Aging (ASMHA).

Chung E, Hui J, Xin Z, Kim S, Moon D, Yuan Y World J Mens Health. 2023; 42(3):471-486.

PMID: 37853539 PMC: 11216964. DOI: 10.5534/wjmh.230180.

Effects of heart failure and coronary artery disease on erectile dysfunction: a two-sample mendelian randomization study.

Shao K, Chen W, Li Y, Zheng H, Hu R, Zhang J BMC Urol. 2023; 23(1):163.

PMID: 37833702 PMC: 10576338. DOI: 10.1186/s12894-023-01335-1.

References

Valenti S, Cuttica C, Fazzuoli L, Giordano G, Giusti M . Biphasic effect of nitric oxide on testosterone and cyclic GMP production by purified rat Leydig cells cultured in vitro. Int J Androl. 1999; 22(5):336-41. DOI: 10.1046/j.1365-2605.1999.00189.x. View

Barrett-Connor E . Sex differences in the association of endogenous sex hormone levels and glucose tolerance status in older men and women. Diabetes Care. 2000; 23(7):912-8. DOI: 10.2337/diacare.23.7.912. View

Harman S, Metter E, Tobin J, Pearson J, Blackman M . Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab. 2001; 86(2):724-31. DOI: 10.1210/jcem.86.2.7219. View

Lin C, Chow S, Lau A, Tu R, Lue T . Identification and regulation of human PDE5A gene promoter. Biochem Biophys Res Commun. 2001; 280(3):684-92. DOI: 10.1006/bbrc.2000.4220. View

MORELAND R, Albadawi H, Bratton C, Patton G, Goldstein I, Traish A . O2-dependent prostanoid synthesis activates functional PGE receptors on corpus cavernosum smooth muscle. Am J Physiol Heart Circ Physiol. 2001; 281(2):H552-8. DOI: 10.1152/ajpheart.2001.281.2.H552. View

Oh J, Barrett-Connor E, Wedick N, Wingard D . Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study. Diabetes Care. 2002; 25(1):55-60. DOI: 10.2337/diacare.25.1.55. View

Aversa A, Isidori A, Caprio M, Cerilli M, Frajese V, Fabbri A . Penile pharmacotesting in diagnosing male erectile dysfunction: evidence for lack of accuracy and specificity. Int J Androl. 2002; 25(1):6-10. DOI: 10.1046/j.1365-2605.2002.00314.x. View

Drewett J, Ho B, Hegge D . Nitric oxide potently inhibits the rate-limiting enzymatic step in steroidogenesis. Mol Cell Endocrinol. 2002; 194(1-2):39-50. DOI: 10.1016/s0303-7207(02)00214-9. View

Lakka H, Laaksonen D, Lakka T, Niskanen L, Kumpusalo E, Tuomilehto J . The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002; 288(21):2709-16. DOI: 10.1001/jama.288.21.2709. View

10.

Niu Y, Ma T, Zhang J, Xu Y, Han R, Sun G . Androgen and prostatic stroma. Asian J Androl. 2003; 5(1):19-26. View

11.

Aversa A, Isidori A, Spera G, Lenzi A, Fabbri A . Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction. Clin Endocrinol (Oxf). 2003; 58(5):632-8. DOI: 10.1046/j.1365-2265.2003.01764.x. View

12.

Malkin C, Pugh P, Jones T, Channer K . Testosterone for secondary prevention in men with ischaemic heart disease?. QJM. 2003; 96(7):521-9. DOI: 10.1093/qjmed/hcg086. View

13.

Meigs J, Wilson P, Nathan D, DAgostino Sr R, Williams K, Haffner S . Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes. 2003; 52(8):2160-7. DOI: 10.2337/diabetes.52.8.2160. View

14.

Kalinchenko S, Kozlov G, Gontcharov N, Katsiya G . Oral testosterone undecanoate reverses erectile dysfunction associated with diabetes mellitus in patients failing on sildenafil citrate therapy alone. Aging Male. 2003; 6(2):94-9. View

15.

Morelli A, Filippi S, Mancina R, Luconi M, Vignozzi L, Marini M . Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa. Endocrinology. 2004; 145(5):2253-63. DOI: 10.1210/en.2003-1699. View

16.

Andersson K, Arner A . Urinary bladder contraction and relaxation: physiology and pathophysiology. Physiol Rev. 2004; 84(3):935-86. DOI: 10.1152/physrev.00038.2003. View

17.

Nieschlag E, Behre H, Bouchard P, Corrales J, Jones T, Stalla G . Testosterone replacement therapy: current trends and future directions. Hum Reprod Update. 2004; 10(5):409-19. DOI: 10.1093/humupd/dmh035. View

18.

Dhindsa S, Prabhakar S, Sethi M, Bandyopadhyay A, Chaudhuri A, Dandona P . Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. J Clin Endocrinol Metab. 2004; 89(11):5462-8. DOI: 10.1210/jc.2004-0804. View

19.

Greenstein A, Mabjeesh N, Sofer M, Kaver I, Matzkin H, Chen J . Does sildenafil combined with testosterone gel improve erectile dysfunction in hypogonadal men in whom testosterone supplement therapy alone failed?. J Urol. 2005; 173(2):530-2. DOI: 10.1097/01.ju.0000149870.36577.05. View

20.

Traish A, Toselli P, Jeong S, Kim N . Adipocyte accumulation in penile corpus cavernosum of the orchiectomized rabbit: a potential mechanism for veno-occlusive dysfunction in androgen deficiency. J Androl. 2005; 26(2):242-8. DOI: 10.1002/j.1939-4640.2005.tb01091.x. View